发明名称 Cerebrospinal meningitis vaccine
摘要 <p>Vaccine against human cerebrospinal meningitis. Microbial strains isolated during an epidemic are separately cultured in vitro by conventional methods, then passaged (48 hrs) several times (pref. 5-6) in the allantoic cavity of the 7-10 day-old chick embryo. Subcultures of the allantoic fluid are used to inoculate industrial cultures. The product is centrifuged, the microbial pellet resuspended, the organisms inactivated (heat, phenol, CH2O, etc.) and then made up into vaccine doses (5-30 strains) contng. 10 billion dead organisms in 0.1 ml., finally lyophilised. Concd. cultures can be obtd., e.g. 500-100 billion organisms per ml., permitting a single intradermal injection of 0.1 ml. of vaccine.</p>
申请公布号 FR1604144(A) 申请公布日期 1971.07.12
申请号 FRD1604144 申请日期 1968.01.29
申请人 发明人
分类号 A61K39/095 主分类号 A61K39/095
代理机构 代理人
主权项
地址